Wei-Min Chen

Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic burden with urinary tubular biomarker abnormalities: a cross-sectional health examination study

Metabolic dysfunction-associated steatotic liver disease (MASLD) frequently coexists with cardiometabolic abnormalities and has been associated with kidney disease. However, its relationship with urinary markers of tubular dysfunction and the extent to which this association overlaps with accompanying cardiometabol...